ASMANEX TWISTHALER
ICS DPI
Mometasone furoate · Organon
Active Medication & Mechanism
- Mometasone furoate ICS110 mcg or 220 mcg per actuation (delivers 100 mcg or 200 mcg from mouthpiece)
Synthetic corticosteroid with potent anti-inflammatory properties. Reduces airway inflammation.
FDA-Approved Dosing by Indication
// approval varies by strength + age Asthma
3/4 approved regimens| Strength | Population | Dose & Frequency | Total Daily | Status |
|---|---|---|---|---|
| 110 mcg | Patients ≥4 years (previously on bronchodilators alone or ICS) | 1 inhalation once daily in the evening For patients 4–11 years, maximum dose is 110 mcg once daily in the evening. | 110 mcg | FDA Approved |
| 220 mcg | Patients ≥12 years (previously on bronchodilators alone or ICS) | 1 inhalation once daily in the evening or 1 inhalation twice daily Recommended starting dose for patients ≥12 years previously on bronchodilators alone or inhaled corticosteroids. | 220–440 mcg | FDA Approved |
| 220 mcg | Patients ≥12 years (previously on oral corticosteroids) | 2 inhalations twice daily Maximum recommended dose. For patients previously on oral corticosteroids. | 880 mcg | FDA Approved |
| Any strength | Acute bronchospasm | — | — | Not Approved Not a bronchodilator. Not for relief of acute bronchospasm. Use a SABA. |
Acute Use
0/1 approved regimens| Strength | Population | Dose & Frequency | Total Daily | Status |
|---|---|---|---|---|
| Any strength | Acute bronchospasm / rescue | — | — | Not Approved Not for acute use. Use a SABA. |